Six Novartis executives, including its CEO, at its Korean location were indicted on charges of paying more than $2 million to doctors in exchange for prescribing its medicines, according to an article in STAT.
In addition, six publishers of medical trade publications and 15 doctors who work at hospitals were also indicted. Novartis allegedly funded academic events that were said to have been organized by the publications, but distributed to doctors with money disguised as attendance fees and for articles that the doctors contributed to the publications, according to the Korea Herald.
These events began in January 2011 through earlier this year, the story said. Read the full article